Lv1
30 积分 2023-08-29 加入
The Global Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among Patients With Type 2 Diabetes
7小时前
待确认
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
1个月前
已完结
A global view of the interplay between non-alcoholic fatty liver disease and diabetes
1个月前
已完结
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis
1个月前
已完结
The pathogenesis of melasma and implications for treatment
4个月前
已完结
Gut microbial co-metabolite 2-methylbutyrylcarnitine exacerbates thrombosis via binding to and activating integrin α2β1
5个月前
已完结
Gut microbial co-metabolite 2-methylbutyrylcarnitine exacerbates thrombosis via binding to and activating integrin α2β1
5个月前
已完结
Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease
5个月前
已完结
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
6个月前
已完结
miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis
10个月前
已完结
皖公网安备34019202002308
